Form 4: SeaStar Medical Director Allan Collins Receives Stock Grant in Lieu of Cash Fees
SEC Form 4 Filing
Director Allan Collins received 37,943 shares of SeaStar Medical Holding Corp common stock in lieu of cash fees for his services as a director.
Summary
- Allan Collins, a director of SeaStar Medical Holding Corp, received 37,943 shares of common stock on April 12, 2024.
- The shares were granted in lieu of a portion of cash fees owed to Collins for his services as a director.
- The shares were valued at $0 and are fully vested upon issuance.
- Following the transaction, Collins directly owns 54,343 shares of SeaStar Medical Holding Corp.
Sentiment
Score: 6
Explanation: The sentiment is neutral. A director receiving stock in lieu of cash can be seen as a positive (conserving cash) or a negative (company not wanting to spend cash).
Positives
- The acquisition of shares by a director could be seen as a positive sign, indicating confidence in the company's future.
Industry Context
Directors receiving stock in lieu of cash compensation is a fairly common practice, especially for smaller companies, as it helps conserve cash.
Stakeholder Impact
- Shareholders may view the stock grant as a positive sign of director alignment with company interests.
- The company conserves cash by issuing stock instead of paying cash fees.
Key Dates
| Date | Description |
|---|---|
| 04/12/2024 | Date of transaction: Allan Collins acquired 37,943 shares of common stock. |
| 04/16/2024 | Date of signature on the Form 4 filing. |
Keywords
SeaStar Medical Holding Corp, Allan Collins, director, stock grant, common stock, beneficial ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.